Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Liposarcoma × plitidepsin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Neoplasm Metastasis 1 Liposarcoma 1

Interventions

Doxorubicin 7 Radiotherapy 6 pazopanib 4 Trabectedin 4 Gemcitabine 4 ribociclib 3 palbociclib 3 eribulin 3 selinexor 2 liposomal doxorubicin 2 avelumab 2 Sunitinib 2 Ifosfamide 2 Docetaxel 2 Cyclophosphamide 2 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2 zimberelimab 1 temsirolimus 1 sotigalimab 1 sodium thiosulfate 1 sitravatinib 1 silmitasertib 1 sargramostim 1 romidepsin 1 regorafenib 1 plitidepsin 1 pembrolizumab 1 pegfilgrastim 1 mirdametinib 1 lenvatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01876043 2021-01-25

APLIPO

Institut Bergonié

Phase 2 Terminated

24 enrolled 10 charts

Liposarcoma, Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡